Cancer deaths are higher among organ transplant recipients
the ONA take:
Transplant patients receive drugs to prevent rejection of the new organ; however, because those drugs suppress the patient’s immune system, they are more susceptible to cancers many years later.
In particular, transplant recipients in Australia have a high risk of skin cancer because of its high UV levels. Researchers at the University of Adelaide are working on understanding this risk and how cancers can be prevented in this population.
This research has uncovered a number of biomarkers that indicate if a transplant patient may be more likely to develop cancer.
The researchers note, however, that they as of yet have no real way of preventing those cancers from occurring. But in an effort to find a balance between ensuring transplanted organs are not rejected and reducing the risk of cancers in these patients, the research team is conducting further studies to determine what the impact reducing immunosuppressants will have on patients.
This research has uncovered a number of biomarkers that indicate if a transplant patient may be more likely to develop cancer
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|